See every side of every news story

Published 18 hours ago • loading... • Updated 18 hours ago

BIOA Deadline: BIOA Investors with Losses in Excess of $100K Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit

Investors in BioAge Labs, Inc. Should note the March 10, 2025, deadline to become a lead plaintiff in a securities lawsuit as stated by Rosen Law Firm.
The lawsuit claims that BioAge misled investors by not disclosing safety concerns tied to its drug candidate Azelaprag.
BioAge discontinued its STRIDES Phase 2 study after subjects showed elevated liver enzyme levels, indicating potential risks.
Rosen Law Firm previously achieved significant settlements for investors, securing over $438 million in 2019 alone.

Insights by Ground AI

Does this summary seem wrong?

21 Articles

21 Articles

All

Left

2

Center

6

Right

1

The Courier Express

+20 Reposted by 20 other sources

BIOA Deadline: BIOA Investors with Losses in Excess of $100K Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit

NEW YORK, Feb. 23, 2025 /PRNewswire/ -

18 hours ago·DuBois, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources21

Leaning Left2Leaning Right1Center6Last Updated2 hours agoBias Distribution

67% Center

Bias Distribution

67% of the sources are Center

67% Center

Untracked bias

+3

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Courier Express broke the news in DuBois, United States 18 hours ago on Sunday, February 23, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics